Litcius/Paper detail

A fluorescence-activatable tumor-reporting probe for precise photodynamic therapy

Jian Li, Tingting Wang, Feng Jiang, Zhangyong Hong, Xinhui Su, Shuang Li, Shoufa Han

2021Journal of Materials Chemistry B13 citationsDOI

Abstract

Approaches that could enable precise photodynamic therapy (PDT) are of therapeutic potential. We herein report a trifunctional probe (Glu-RdEB) that could be activated to generate fluorescent rhodamine species to pinpoint tumor foci. The probe contains a γ-glutaminyl moiety cleavable to γ-glutamyl transpeptidase (GGT) overexpressed in multiple tumors, an entity of an ENBS photosensitizer for PDT, and an entity of rhodamine fluorescently quenched by ENBS. Upon activation by tumor-associated GGT, the probe releases highly fluorescent rhodamine that is selectively confined in tumors whereby light irradiation leads to effective tumor regression in mice. These results indicate the feasibility of a fluorescently quenched dye-photosensitizer pair to yield tumor-activatable fluorescence to direct PDT.

Topics & Concepts

Photodynamic therapyFluorescenceMaterials scienceNanotechnologyMedicineMedical physicsOpticsChemistryOrganic chemistryPhysicsNanoplatforms for cancer theranosticsPhotodynamic Therapy Research StudiesLuminescence and Fluorescent Materials
A fluorescence-activatable tumor-reporting probe for precise photodynamic therapy | Litcius